Probably for as long as surgeons have implanted artificial hips and knees, manufacturers enjoyed the enviable position of being able to set prices. Unable to fall back to the relative safety net of group purchasing contracts and finding themselves compelled to cede to surgeons’ demands for their implant product and supplier of choice, hospitals had little alternative but to pay for the implant, very often at list price.